N-Arachidonylglycine ≥98% (durch TLC)
Lieferant: ENZO LIFE SCIENCES AG
ENZOBMLFA0290005EA
67
CHF
ENZOBMLFA0290005
N-Arachidonylglycine ≥98% (durch TLC)
N-Arachidonylglycine
FAAH inhibitor
Endogenous anandamide-like compound. Lacks affinity for CB1 receptors (Ki>10µM), TRPV1 (EC50>10µM) and anandamide uptake (IC50>50µM), but inhibits fatty acid amide hydrolase (FAAH) (IC50=8.5µM-50µM, depending on cell type and species). Displays anti-inflammatory and analgesic activity. Identified as an insulin secretagogue in a primary beta-cell-based functional assay. Represents a new class of "lipoamino acids".
Formel:
C₂₂H₃₅NO₃ MW: 361,526 g/mol |
MDL Number:
MFCD03791313 CAS-Nummer: 179113-91-8 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...